Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway.

Saved in:
Bibliographic Details
Title: Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway.
Authors: Hu AM; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Chen M; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Zhu CC; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Zhu ZM; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China., Xu XH; School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China.; Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases, Wannan Medical College, Wuhu, 241002, China.
Source: Biochemistry and biophysics reports [Biochem Biophys Rep] 2026 Jan 15; Vol. 45, pp. 102454. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101660999 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5808 (Electronic) Linking ISSN: 24055808 NLM ISO Abbreviation: Biochem Biophys Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-5808
DOI:10.1016/j.bbrep.2026.102454